GVK BIO Announces Successful Completion Of Drug Repurposing
00:00
00:00
Embed Code (recommended way)
Embed Code (Iframe alternative)
Please login or signup to use this feature.

GVK Biosciences (GVK BIO) – Asia’s leading integrated Discovery Research and Development organization today announced the successful completion of in-silico based alternative indications of shelved compounds for Takeda Pharmaceutical Company Limited using GVK BIO’s proprietary Drug Repurposing Platform.

Licence : All Rights Reserved


X